Ascendis Pharma A/S (ASND) Earnings Date & Reports

Ascendis Pharma AS is a biopharmaceutical company that applies its TransCon technology platform to make a meaningful difference for patients... Show more

Industry: #Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

ASND is expected to report earnings to rise 459.26% to $1.51 per share on August 06

Ascendis Pharma A/S ASND Stock Earnings Reports

Q2'26

Est.

$1.51

Q1'26

Beat

by $0.09

Q4'25

Missed

by $0.40

Q3'25

Missed

by $0.72

Q2'25

Beat

by $0.45

The last earnings report on May 07 showed earnings per share of 27 cents, beating the estimate of 18 cents. With 241.20K shares outstanding, the current market capitalization sits at 17.38B.

View a ticker or compare two or three

Compare

ASND

Setup

Daily Signal:

Description

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

Last 5 trading days

View AI-Driven Trading for ASND